The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
Biotech stocks rebounded in 2025. Wedbush’s Laura Chico explains why rare disease catalysts and upcoming data could shape the ...
Will this biotech's innovative platform finally pay off?
Investor's Business Daily on MSN
China biotech lights up. US stocks prepare for a new powerhouse.
U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...
Goldman Sachs believes that Biohaven offers investors an under-the-radar opportunity to invest in a potentially best-in-class ...
Artificial intelligence (AI) isn't the only industry with explosive growth potential.
Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional ...
There's a growth stock that has skyrocketed more than Google parent Alphabet ( GOOG 0.04%) ( GOOGL 0.07%) and Nvidia ( NVDA 0 ...
Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...
CalciMedica had been evaluating the therapy, called Auxora, in the Kourage trial of patients with stage 2 or 3 AKI with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results